ARS Pharmaceuticals Inc’s recent filing unveils that its Officer Chakma Justin acquired Company’s shares for reported $4.09 million on Nov 15 ’24. In the deal valued at $17.30 per share,236,380 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Tanimoto Sarina sold 100,000 shares, generating $1,684,642 in total proceeds. Upon selling the shares at $16.85, the CHIEF MEDICAL OFFICER now owns 1,248,499 shares.
Before that, Lowenthal Richard E sold 100,000 shares. ARS Pharmaceuticals Inc shares valued at $1,684,642 were divested by the PRESIDENT AND CEO at a price of $16.85 per share. As a result of the transaction, Lowenthal Richard E now holds 1,248,499 shares, worth roughly $17.49 million.
Cantor Fitzgerald initiated its ARS Pharmaceuticals Inc [SPRY] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in mid August from “an Outperform” to “a Strong buy”. Leerink Partners also remained covering SPRY and reiterated its “an Outperform” recommendation on August 12, 2024. Raymond James started covering the stock on July 25, 2024. It rated SPRY as “an Outperform”.
Price Performance Review of SPRY
On Friday, ARS Pharmaceuticals Inc [NASDAQ:SPRY] saw its stock fall -0.71% to $14.01. Over the last five days, the stock has lost -17.78%. ARS Pharmaceuticals Inc shares have risen nearly 155.66% since the year began. Nevertheless, the stocks have risen 209.27% over the past one year. While a 52-week high of $18.51 was reached on 11/11/24, a 52-week low of $4.27 was recorded on 01/04/24. SMA at 50 days reached $14.63, while 200 days put it at $10.78.
Levels Of Support And Resistance For SPRY Stock
The 24-hour chart illustrates a support level at 13.45, which if violated will result in even more drops to 12.90. On the upside, there is a resistance level at 14.47. A further resistance level may holdings at 14.93. The Relative Strength Index (RSI) on the 14-day chart is 41.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.38%. Stochastics %K at 8.45% indicates the stock is a buying.
How much short interest is there in ARS Pharmaceuticals Inc?
A steep rise in short interest was recorded in ARS Pharmaceuticals Inc stocks on 2024-10-31, growing by 1.5 million shares to a total of 12.6 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 11.1 million shares. There was a rise of 11.91%, which implies that there is a positive sentiment for the stock.
